» Articles » PMID: 16573375

Case-control Analysis of Dietary Folate and Risk of Bladder Cancer

Overview
Journal Nutr Cancer
Publisher Routledge
Date 2006 Apr 1
PMID 16573375
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Dietary folate, a water-soluble B vitamin found in a variety of fruits and vegetables, is of particular interest as a chemopreventive agent due to its role in DNA methylation and DNA synthesis and repair. We hypothesized that individuals with low folate intake would be at an increased risk for bladder cancer. Using an ongoing case-control study we assessed dietary folate in 409 incident bladder cancer patients and 451 healthy control subjects. A food-frequency questionnaire was used to estimate naturally occurring food folate (microg/kcal/day), dietary folate equivalents (DFE) from food sources (microg DFE/kcal/day), and DFE from all sources (microg DFE/kcal/day). Unconditional logistic regression analyses were used to estimate odds ratios (ORs) and 95% confidence intervals (CIs). Bladder cancer patients reported a statistically significant lower intake of folate than control subjects for food folate and DFE from food sources (P < 0.001) but not for DFE from all sources (P = 0.061). In the highest quartile of food folate intake there was a 54% reduced risk for bladder cancer (OR = 0.46; 95% CI = 0.29-0.73) after adjusting for age, gender, ethnicity, smoking, and total energy intake. Similarly, the highest quartile of intake was associated with a 59% reduced risk for DFE from food sources (OR = 0.41; 95% CI = 0.26-0.65) and a 35% reduced risk for DFE from all sources (OR = 0.65; 95% CI = 0.42-1.00). In the joint-effects analyses using never smokers with high folate intake as the reference group (OR = 1.0), heavy smokers with low food folate intake had a 2.31-fold (95% CI = 1.11-4.82) increased risk, whereas heavy smokers with high folate intake had a reduced OR of 1.31 (95% CI = 0.53-3.26). Although the ORs were not statistically significant, light smokers and high folate intake exhibited a protective effect (OR = 0.62; 95% CI = 0.20-1.94), whereas an increased risk was observed for light smoking and low folate intake (OR = 1.41; 95% CI = 0.57-3.45). These patterns were consistent for the joint effects of smoking and DFE from food sources and DFE from all sources. In summary, high intake of dietary folate was associated with an overall decrease in bladder cancer risk. These data may have important implications for cancer prevention; however, large, hypothesis-driven, population-based clinical trials will be required to confirm these findings.

Citing Articles

The association of the Affordable Care Act with nutrient consumption in adults in the United States.

Kirk H, Tufuor T, Shaver A, Nie J, Devarshi P, Marshall K Front Public Health. 2024; 11:1244042.

PMID: 38186698 PMC: 10768893. DOI: 10.3389/fpubh.2023.1244042.


Dietary B group vitamin intake and the bladder cancer risk: a pooled analysis of prospective cohort studies.

Boot I, Wesselius A, Yu E, Brinkman M, van den Brandt P, Grant E Eur J Nutr. 2022; 61(5):2397-2416.

PMID: 35129646 PMC: 9279207. DOI: 10.1007/s00394-022-02805-2.


One-carbon metabolism biomarkers and risk of urothelial cell carcinoma in the European prospective investigation into cancer and nutrition.

Vrieling A, Bueno-de-Mesquita H, Ros M, Kampman E, Aben K, Buchner F Int J Cancer. 2019; 145(9):2349-2359.

PMID: 30694528 PMC: 6899898. DOI: 10.1002/ijc.32165.


Is folic acid safe for non-muscle-invasive bladder cancer patients? An evidence-based cohort study.

Tu H, Dinney C, Ye Y, Grossman H, Lerner S, Wu X Am J Clin Nutr. 2018; 107(2):208-216.

PMID: 29529165 PMC: 6669327. DOI: 10.1093/ajcn/nqx019.


Expression of RFC/SLC19A1 is associated with tumor type in bladder cancer patients.

Abdel-Haleem A, El-Zeiry M, Mahran L, Abou-Aisha K, Rady M, Rohde J PLoS One. 2011; 6(7):e21820.

PMID: 21760912 PMC: 3132752. DOI: 10.1371/journal.pone.0021820.